Director Shrhldg-Replacement

GlaxoSmithKline PLC
06 September 2002



This announcement replaces the announcement released today at 15:56, under RNS
number 8747A, which had already been released at 15.55 on 3 September 2002 under
RNS number 7055A.

The full corrected version is shown below.



                              Directors' Interests

I give below details of changes in directors' interests in the Ordinary Shares
of GlaxoSmithKline plc.

05 September 2002                 The Administrators of the GlaxoSmithKline US Retirement Savings Plan ("the
                                  Plan") notified GlaxoSmithKline plc on the 6 September 2002, that as a result of
                                  movement in the fund on the 05 September 2002, the number of Ordinary Share ADRs
                                  held by the fund had decreased from 18,206,985 to 18,184,226 at an average price
                                  of $37.13.


The Trust is a discretionary fund of which all employees or former employees of
GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two of the
Company's directors, Dr J P Garnier and Mr J D Coombe are therefore interested
in the shares held in the fund from time to time in the same way as other
employees or former employees of GlaxoSmithKline plc and its subsidiaries.



S M Bicknell
Company Secretary


6 September 2002


                      This information is provided by RNS
            The company news service from the London Stock Exchange